Family system characteristics and psychological adjustment to cancer susceptibility genetic testing

Autor: A H J T Bröcker-Vriends, A. R. Van Gool, Hugo J. Duivenvoorden, C. J. van Asperen, I. van Oostrom, Caroline Seynaeve, Hanne Meijers-Heijboer, Rolf H. Sijmons, J.G.M. Klijn, Aad Tibben

Publikováno v: Clinical Genetics, 71, 35-42
Clinical Genetics, 71(1), 35-42. Wiley
Clinical genetics, 71(1), 35-42. Wiley-Blackwell
Clinical Genetics, 71(1), 35-42. Wiley-Blackwell Publishing Ltd
Clinical Genetics, 71, 1, pp. 35-42

Item does not contain fulltext This study examined prospectively the contribution of family functioning, differentiation to parents, family communication and support from relatives to psychological distress in individuals undergoing genetic susceptib

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c8ccc04a651446cb3c805d9ebf338bc
https://research.rug.nl/en/publications/441340ba-a883-4f25-a76c-64cd550e291a

The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy

Autor: Caroline Seynaeve, Aad Tibben, Martinus F. Niermeijer, Hugo J. Duivenvoorden, S. van Dooren, A. R. Van Gool, Marian B. E. Menke-Pluijmers, J.G.M. Klijn, A.N. van Geel, Paula J.C. Bresser

Publikováno v: European Journal of Cancer, 43, 1, pp. 95-103
European Journal of Cancer, 43, 95-103
European Journal of Cancer, 43(1), 95-103. Elsevier Ltd.

Contains fulltext : 52416.pdf (Publisher’s version ) (Closed access) The levels and course of psychological distress before and after prophylactic mastectomy (PM) and/or prophylactic salpingo-oophorectomy (PSO) were studied in a group of 78 women.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::933750d2eed6e760e027e9a99ea2bbb7
https://hdl.handle.net/2066/52416

Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer

Autor: Nicoline Hoogerbrugge, Sybren L. Meijer, H.J. de Koning, Jan C. Oosterwijk, Theo Kok, Carla Boetes, H. M. Zonderland, A. P. E. Besnard, Caroline Seynaeve, Inge Marie Obdeijn, R. A. Manoliu, Mieke Kriege, Hans Peterse, Madeleine M. A. Tilanus-Linthorst, Sara H. Muller, E.J.T. Rutgers, C.C.M. Bartels, J.G.M. Klijn, C.T.M. Brekelmans, Rob A. E. M. Tollenaar

Publikováno v: Breast cancer research and treatment, 102(3), 357-363. Springer New York
Breast Cancer Research and Treatment, 102(3), 357-363. Springer New York
Breast Cancer Research and Treatment, 102, 357-63
Breast Cancer Research and Treatment, 102(3), 357-363. SPRINGER
Breast Cancer Research and Treatment, 102, 3, pp. 357-63

In the MRISC study, women with an inherited risk for breast cancer were screened by a 6-month clinical breast examination (CBE) and yearly MRI and mammography. We found that the MRISC screening scheme could facilitate early breast cancer diagnosis an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfd783fc8191dfdcdc6e57c135bc50f5
https://doi.org/10.1007/s10549-006-9341-6

Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapy

Autor: L. Ottestad, Per Eystein Lønning, J.G.M. Klijn, W. Mietlowski, M. Csepreghy, J.P. Guastalla, E. Baltali, H. Sommer, S.I. Helle, I. Szakolczai, C. Boni, T. Pinter, C. Bryce, Emilio Bajetta

Publikováno v: European Journal of Cancer, 41(5), 694-701. Elsevier Ltd.

The insulin-like growth factor (IGF)-system was evaluated in 150 breast cancer patients participating in a randomised phase III trial comparing octreotide pamoate and tamoxifen with tamoxifen+placebo. Alterations in the IGF-system in the two treatmen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fc9e298236bb3329ec11f6ff3f649c1
https://doi.org/10.1016/j.ejca.2004.12.015

Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant

Autor: G. H. de Bock, Peter Devilee, J.G.M. Klijn, C. J. Cornelisse, Mieke Schutte, R.A.E.M. Tollenaar, Hanne Meijers-Heijboer, Caroline Seynaeve, J. Blom, C.T.M. Brekelmans, E M M Krol-Warmerdam, C. J. van Asperen

Publikováno v: Journal of medical genetics, 41(10), 731-735. BMJ Publishing Group
JOURNAL OF MEDICAL GENETICS, 41(10), 731-735. BMJ PUBLISHING GROUP
Journal of Medical Genetics, 41, 731-735. BMJ Publishing Group

Background: The germline CHEK2*1100delC variant has been associated with breast cancer in multiple case families where involvement of BRCA1 and BRCA2 has been excluded.Methods: We have investigated the tumour characteristics and prognosis of carriers

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::776418543274609fa6901369f0d24ac6
https://pure.eur.nl/en/publications/ba1a800b-9a66-4fc7-aa0c-fcd0bd975859